-
, and the ever-changing regulatory environment requires forward thinking and attention to detail. Your dedication and expertise will help expand and accelerate patient access to Pfizer medicines. What You
-
changing needs of the regulatory environment Works with RQA colleagues on cross GxP audit plans as required Coaches colleagues - leads training for routine and non-routine site and process audits Advises
-
and regulatory operations and environment in countries under responsibility English is required. Prior Experience Demonstrated clinical research experience and/or study management/startup project
-
, and the ever-changing regulatory environment requires forward thinking and attention to detail. Your dedication and expertise will help expand and accelerate patient access to Pfizer medicines. What You
-
transparent environment that encourages strong partnerships and mutual trust between teams, sub-teams, and therapeutics areas. Accountable to multiple project/core study teams and clinical sub-teams and manages
-
. High attention to detail. Ability to consolidate comments from multiple sources (e.g., emails, meeting minutes). NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS Ability to flex working
-
development process, related to monitoring clinical trials, GCP, FDA, or country-specific regulatory environment Demonstrated success in prior scientific/technical/administrative roles Demonstrated experience
-
, and the ever-changing regulatory environment requires forward thinking and attention to detail. Your dedication and expertise will help expand and accelerate patient access to Pfizer medicines. What You
-
transparent environment that encourages strong partnerships and mutual trust between teams, sub-teams, and therapeutics areas. Accountable to multiple project/core study teams and clinical sub-teams and manages
-
analytical abilities and problem-solving skills. Ability to provide leadership, set priorities and be accountable to timeline . Training in a GCLP/GLP/GMP environment and other international regulatory